EFTA00977795.pdf

From: Jeffrey Epstein <[email protected]> To: Subject: Re: Joe Thakuria Date: Wed, 04 Dec 2013 17:19:06 +0000 have him send an invoice On Wed, Dec 4, 2013 at 11:16 AM, wrote: from Joe Thakuria...a follow up to his last email... It's exciting since with the exception of the clinical whole genome (that Illumina has offered for years but at a very low volume due to cost and very limited clinical indication (for now)), the other stuff (including the clinical exomes) hasn't really even been around beyond a year or so. The iPS cell lines would have been something you could only get from a handful of labs worldwide and, even then, the researchers would most likely be prioritizing their own projects - not doing "one-off" individualized cell lines for interested parties. Anyway, I'll make sure he gets access to the latest and greatest and he can choose those things that are of the greatest scientific and personal interest for him from the list. Maybe along the way also help some of these kids with genetic disorders that we haven't been able to molecularly diagnose through conventional Sanger sequencing at MGH. Cheers, Joe The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jea®gmail.com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00977795